Patent · US Active

DPP IV inhibitor formulations

US11033552B2 · kind B2 · utility

7Cited by

161References

16Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Anja Kohlrausch · Biberach, DE
Patrick ROMER · Jüterbog, DE
Gerd SEIFFERT · Laupheim, DE

Key dates

Filing date	Mar 19, 2019
Grant date	Jun 15, 2021
Priority date	—
Expiry date	Mar 19, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/2077
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to pharmaceutical compositions of DPP IV inhibitors with an amino group, their preparation and their use to treat diabetes mellitus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.